Skip to main content
. 2022 Jul 18;13:939869. doi: 10.3389/fphar.2022.939869

TABLE 3.

Description of doses and duration of treatment for drugs prescribed as continuous infusion

Molecules, N (%) n=n. patients with continuous infusion/N patients with a prescription of the molecule N patients with a loading dose (%) Loading dose (dose/kg) Initial dose (dose/kg) Mean maintenance dose (dose/kg/h) Cumulative dose (dose/kg) Duration of treatment (days)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR)
p2.5 – p97.5 p2.5 – p97.5 p2.5 – p97.5 p2.5 – p97.5 p2.5 – p97.5
Opioids and derivatives
Sufentanil (µg/kg) n=6580/6751 (97.5%) 842 (12.8%) 0.40 (0.73) 0.23 (0.33) 0.27 (0.23) 50.9 (131.6) 6.6 (8.9)
0.2 (0.2-0.5) 0.2 (0.2-0.2) 0.2 (0.18 - 0.31) 16.0 (6.0–43.6) 4 (2-7)
0.1–0.6 0.05–0.5 0.05 - 0.84 1.2–314.6 1–33
Morphine (µg/kg) n=3934/5213 (75.5%) 66 (1.7%) 32.5 (16.5) 18.5 (28.5) 24.6 (116.8) 5089 (32123) 7.0 (8.8)
25 (20–50) 10 (10-20) 19.1 (10-27.3) 1427 (480-4137) 4 (2-8)
15–54 5–50 5 - 64.9 113 - 26638 1–33
Fentanyl (µg/kg) n=1122/1141 (98.3%) 21 (1.9%) 1.0 (0.5) 0.80 (0.47) 1.1 (0.6) 236 (404) 8.2 (10.0)
1 (1–1) 0.5 (0.5-1) 1 (0.5-1.4) 86 (25–255) 5 (2-9)
0.5–2 0.2– 2 0.3 - 2.5 4.8–1316 1–34
Remifentanil (µg/kg) n=24/24 (100%) 17 (70.8%) 0.65 (0.23) 29.3 (15.7) 29.4 (15.0) 690.5 (618) 1.4 (0.6)
0.5 (0.5–1) 30 (30-30) 30 (30-30) 720 (200-758) 1 (1-2)
0.5–1 0.06 - 60 0.3–60 6.2–2033 1–2.4
Nalbuphine (mg/kg) n=159/1814 (8.8%) 4 (2.5%) 0.13 (0.09) 0.05 (0.09) 0.06 (0.09) 2.7 (3.6) 2.6 (1.8)
0.15 (0.08–0.2) 0.05 (0.02-0.05) 0.05 (0.03-0.05) 1.6 (1.0 – 3.0) 2 (1-3)
0.03–0.2 0.015 - 0.18 0.017–0.18 0.2–13 1–7
Sedatives
Midazolam (µg/kg) n=5808/6052 (96.0%) 140 (2.4%) 76 (64) 46.9 (880) 40.3 (43.4) 8547 (32850) 7.1 (10.2)
50 (50–100) 30 (20-30) 30 (20-47) 2234 (919 - 6484) 4 (2-8)
10–200 6–100 6.3–136 144 – 53928 1 – 34
Clonidine (µg/kg) n=147/168 (87.5%) 1 (0.7%) 1 0.42 (0.18) 0.55 (0.27) 193.1 (307.6) 12.3 (12.3)
0.5 (0.3-0.5) 0.5 (0.38-0.7) 78.5 (29.2 - 218.3) 8 (4-16.5)
0.02–0.76 0.12–1.02 9.4 - 866 2 - 37
Dexmedetomidine (µg/kg) n=41/41 (100%) 27 (65.9%) 0.05 (0.01) 0.093 (0.09) 0.17 (0.08) 38.1 (38.6) 8.9 (6.6)
0.05 (0.05-0.05) 0.05 (0.05-0.1) 0.17 (0.11-0.2) 24.0 (15.7-51.6) 6 (5-12)
0.04 – 0.05 0.05–0.2 0.05–0.28 1.5–133 1 - 25
Anesthetics
Ketamine (mg/kg) N = 165/3498 (4.7%) 9 (5.5%) 0.9 (0.67) 0.9 (2.2) 1.16 (3.6) 190.9 (498.7) 8.0 (13.2)
0.5 (0.5-1) 0.5 (0.12-1) 0.57 (0.3-1.0) 33.2 (12-172.8) 4 (1-10)
0.3–2 0.04 - 3.8 0.05 - 3.3 1.0 - 973 1 - 42
Propofol (mg/kg) N = 64/2131 (3.0%) 5 (7.8%) 1.6 (0.9) 2.8 (2.8) 3.0 (2.8) 200 (682) 3.5 (9.7)
1 (1-2) 2 (1-3) 2 (1-3.1) 48 (24-164) 1 (1-2)
1–2.9 0.5 - 9 0.6 - 9 1.8 - 1101 1 - 22
Thiopental (mg/kg) n=18/47 (38.3%) 6 (33.3%) 3.5 (0.837) 5.9 (18.5) 6.0 (18.5) 317 (887) 2.6 (1.9)
3 (3-3.75) 1 (1-2) 1.6 (1-2.2) 48 (24.8 -236) 2 (1-2.8)
3–4.9 0.1 - 48 0.1 - 48 0.6 - 2403 1 - 6.6
Paralytics
Atracurium (mg/kg) n=353/585 (60.3%) 136 (38.5%) 0.29 (0.11) 0.37 (0.12) 0.43 (0.2) 38.2 (106.5) 3.3 (3.3)
0.25 (0.250.3) 0.4 (0.3-0.4) 0.4 (0.3–0.47) 15.9 (9.6-32.3) 2 (2-4)
0.22–0.5 0.2 - 0.6 0.2–1 1.75–215.7 1–10.2
Rocuronium (mg/kg) n=14/23 (60.9%) 3 (21.4%) 0.25 (0.3) 0.3 0.35 (0.10) 26.9 (30.8) 3.4 (2.3)
0.075 (0.075-0.34) 0.3 (0.3–0.365) 17.4 (13.2–25.2) 3 (2–3.7)
0.075–0.57 0.3–0.6 4.0 – 101 1–8.3
Vecuronium (mg/kg) n=6/8 (75%) 4 (66.6%) 0.01 0.05 0.61 (0.66) 0.05 1.2 (0.41)
0.61 (0.01–1.2) 1 (1–1)
0.006–1.2 1–1.9
Antidotes
Naloxone (µg/kg) n=12/452 (2.7%) 4 (33.3%) 32.5 (45) 6.8 (14.1) 6.7 (14.1) 293.1 (645.0) 2.25 (1.8)
10 (10–32.5) 2 (0.24–6.25) 2 (0.24–5.0) 49.5 (8.5–220.8) 1.5 (1–2.5)
10–93 0.06–39 0.06–39 0.3–1783 1–5.7
Flumazenil (µg/kg) n=9/28 (32.1%) 9 (100%) 0.01 0.005 0.005 0.09 (0.05) 1.2 (0.4)
0.1 (0.05–0.12) 1 (1–1)
0.007–0.16 1–2

Results are presented as mean (standard deviation), median (interquartile) and 2.5 – 97.5 percentile range (to exclude extreme values).